ML 145
|
|
|
- CAS号:
- 1164500-72-4
- 英文名:
- ML 145
- 英文别名:
- ML 145;2-Hydroxy-4-[4-(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid;Benzoic acid, 2-hydroxy-4-[[4-[(5Z)-5-[(2E)-2-methyl-3-phenyl-2-propen-1-ylidene]-4-oxo-2-thioxo-3-thiazolidinyl]-1-oxobutyl]amino]-
- 中文名:
- ML 145
- 中文别名:
- 化合物 T12074
- CBNumber:
- CB42535683
- 分子式:
- C24H22N2O5S2
- 分子量:
- 482.57188
- MOL File:
- 1164500-72-4.mol
|
|
|
ML 145化学性质
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble to 100 mM in DMSO
-
|
-
形态:
-
Powder
-
|
ML 145性质、用途与生产工艺
ML 145 是选择性，竞争性的人 GPR35/CXCR8 拮抗剂，IC50/EC50 为 20.1 nM。ML 145 对 GPR35 的选择性比 GPR55 (IC50/EC50=21.7 μM) 高超 1000 倍。 ML 145 对啮齿动物直系同源物的 GPR35 均无明显活性。
IC50/EC50: 20.1 nM (GPR35), 21.7 μM (GPR55)
ML 145 (10 μM) also fully blocks internalization of human FLAG-GPR35-eYFP in response to varying concentrations of Zaprinast, Cromolyn disodium, and Pamoate.
ML 145 is either without effect (mouse) or displays only a small and apparently noncompetitive inhibitory effect (rat) at the rodent orthologs.
ML 145 acts as a competitive antagonist for a number of agonists at human GPR35 and has an IC
50
value against EC
80
concentrations of various GPR35 agonists in the region of 20 nM.
ML 145
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-107536 | ML 145
ML 145 | 1164500-72-4 | 5mg | 1200元 |
| 2024/04/30 | HY-107536 | ML 145
ML 145 | 1164500-72-4 | 10mM * 1mLin DMSO | 1320元 |
1164500-72-4, ML 145 相关搜索:
- 化合物 T12074
- 1164500-72-4
- Benzoic acid, 2-hydroxy-4-[[4-[(5Z)-5-[(2E)-2-methyl-3-phenyl-2-propen-1-ylidene]-4-oxo-2-thioxo-3-thiazolidinyl]-1-oxobutyl]amino]-
- 2-Hydroxy-4-[4-(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid
- ML 145